ORIGINAL PAPER
Analysis of periodontal status in Polish patients with rheumatoid arthritis treated with biological therapies
More details
Hide details
1
Private Dental Practice Joanna Samborska, Poznan, Poland
2
Department of Rheumatology, Rehabilitation and Internal Medicine, Poznan University of Medical Sciences, Poland
3
Chair and Department of Dental Surgery, Periodontology, and Oral Mucosa Diseases, Poznan University of Medical Sciences, Poland
These authors had equal contribution to this work
Submission date: 2024-06-27
Final revision date: 2024-09-25
Acceptance date: 2024-10-13
Online publication date: 2024-11-09
Corresponding author
Marzena Liliana Wyganowska
Chair and Department of Dental Surgery, Periodontology, and Oral Mucosa Diseases, Poznan University
of Medical Sciences, 70 Bukowska St., 60-812 Poznan, Poland, e-mail: marzena.wyganowska@periona.pl
Reumatologia 2024;62(5):351-359
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Periodontitis, characterized by inflammation affecting the tooth-supporting tissues, may increase the risk of rheumatoid arthritis (RA) or cardiovascular diseases. The aim of the study was to evaluate the periodontal status in RA patients and its impact on the inflammatory markers and red cell parameters obtained from complete blood laboratory tests to study the risk of cardiovascular disease development.
Material and methods:
The cross-sectional study included 50 patients with RA treated with biological therapies: tumor necrosis factor inhibitors, interleukin-6 blockers. Rheumatoid arthritis disease activity was assessed with Disease Activity Score with 28-joint count (DAS28). The periodontal indices modified Approximal Periodontal Index, modified Papillary Bleeding Index, and Periodontal Screening Index (PSI) were used to assess patients’ periodontal status. Serum levels of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were used as inflammatory markers and a potential cardiovascular risk factor.
Results:
No statistically significant correlation was found between the periodontal status and RA activity. However, a statistically significant correlation was found between the CRP results and the PSI scores (R = –0.264510, p = 0.048837). Evaluation of the red cell parameters showed statistically significant differences in the markers of inflammation ESR (R = 0.369398, p = 0.008289) and CRP (R = 0.367405, p = 0.008672). Red cell distribution width values were also correlated with RA activity (R = 0.286387, p = 0.043769) and duration of the disease (R = 0.339425, p = 0.015889).
Conclusions:
A satisfactory periodontal status was found in most of the study group. Increased CRP levels in patients with periodontitis may indicate the negative impact of periodontal status on the general clinical condition of the patient.
REFERENCES (32)
1.
Klareskog L, Rönnelid J, Saevarsdottir S, et al. The importance of differences; On environment and its interactions with genes and immunity in the causation of rheumatoid arthritis. J Intern Med 2020; 287: 514–533, DOI: 10.1111/joim.13058.
2.
Koziel J, Potempa J. Pros and cons of causative association between periodontitis and rheumatoid arthritis. Periodontol 2000 2022; 89: 83–98, DOI: 10.1111/prd.12432.
3.
Tang Q, Fu H, Qin B, et al. A Possible Link Between Rheumatoid Arthritis and Periodontitis: A Systematic Review and Meta-analysis. Int J Periodontics Restorative Dent 2017; 37: 79–86, DOI: 10.11607/prd.2656.
4.
de Molon RS, Rossa C Jr, Thurlings RM, et al. Linkage of periodontitis and rheumatoid arthritis: current evidence and potential biological interactions. Int J Mol Sci 2019; 20: 4541–4576, DOI: 10.3390/ijms20184541.
5.
Ceccarelli F, Saccucci M, Di Carlo G, et al. Periodontitis and Rheumatoid Arthritis: The Same Inflammatory Mediators? Mediators Inflamm 2019; 2019: 6034546, DOI: 10.1155/2019/6034546.
6.
Rak D, Kulloli AM, Shetty SK, et al. Correlation between rheumatoid arthritis and chronic periodontitis: a systematic review and meta-analysis. Minerva Dent Oral Sci 2024; 73: 294–302, DOI: 10.23736/S2724-6329.23.04891-X.
7.
Reynolds MA. Modifiable risk factors in periodontitis: at the intersection of aging and disease. Periodontol 2000 2014; 64: 7–19, DOI: 10.1111/prd.12047.
8.
Wang S, Wang Y. Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis. Biochim Biophys Acta 2013; 1829: 1126–1135, DOI: 10.1016/j.bbagrm.2013.07.003.
9.
Wegner N, Wait R, Sroka A, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and -enolase: Implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum 2010; 62: 2662–2672, DOI: 10.1002/art.27552.
10.
Hachim SK, Abbas AA, Alosami MH. Association of Porphyromonus gingivalis with rheumatoid arthritis. Iraqi JMS 2016; 14: 231–236.
11.
Sahingur SE, Xia XJ, Alamgir S, et al. DNA from Porphyromonas gingivalis and Tannerella forsythia induce cytokine production in human monocytic cell lines. Mol Oral Microbiol 2010; 25: 123–135, DOI: 10.1111/j.2041-1014.2009.00551.x.
12.
Malysheva K, de Rooij K, Lowik CW, et al. Interleukin 6/Wnt interactions in rheumatoid arthritis: interleukin 6 inhibits Wnt signaling in synovial fibroblasts and osteoblasts. Croat Med J 2016; 57: 89–98, DOI: 10.3325/cmj.2016.57.89.
13.
Noh MK, Jung M, Kim SH, et al. Assessment of IL-6, IL-8 and TNF- levels in the gingival tissue of patients with periodontitis. Exp Ther Med 2013; 6: 847-851, DOI: 10.3892/etm. 2013.1222.
14.
Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003; 74: 391–401, DOI: 10.1902/jop.2003.74.3.391.
15.
Zhao B, Li X, Li R. Genetic Relationship Between IL-6 rs1800796 Polymorphism and Susceptibility to Periodontitis. Immunol Invest 2019; 48: 268–282; DOI: 10.1080/08820139.2018.1517365.
16.
Machado V, Botelho J, Escalda C, et al. Serum C-Reactive Protein and Periodontitis: A Systematic Review and Meta-Analysis. Front Immunol 2021; 28: 12:706432, DOI: 10.3389/fimmu.2021.706432.
17.
van Gestel AM, Prevoo ML, van’t Hof MA, et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996; 39: 34–40, DOI: 10.1002/art.1780390105.
18.
Zawada L, Konopka T. New periodontal indices. Dent Med Probl 2011; 48: 243–250.
19.
Chapple ILC, Van der Weijden F, Doerfer C, et al. Primary prevention of periodontitis: managing gingivitis. J Clin Periodontol 2015; 42 (Suppl 16): S71–S76, DOI: 10.1111/jcpe.12366.
20.
Lewis MJ. Predicting best treatment in rheumatoid arthritis. Semin Arthritis Rheum 2024; 64S: 152329, DOI: 10.1016/j.semarthrit. 2023.152329.
21.
Inchingolo F, Inchingolo AM, Avantario P, et al. The Effects of Periodontal Treatment on Rheumatoid Arthritis and of Anti-Rheumatic Drugs on Periodontitis: A Systematic Review. Int J Mol Sci 2023; 24: 17228, DOI: 10.3390/ijms242417228.
22.
Craig RG, Yip JK, So MK, et al. Relationship of destructive periodontal disease to the acute phase response. J Periodontal 2003; 74: 1007–1016, DOI: 10.1902/jop.2003.74.7.1007.
23.
Rodríguez-Lozano B, González-Febles J, Garnier-Rodríguez JL, et al. Association between severity of periodontitis and clinical activity in rheumatoid arthritis patients: a case-control study. Arthritis Res Ther 2019; 21: 27–39, DOI: 10.1186/s13075-019-1808-z.
24.
Rovas A, Puriene A, Punceviciene E, et al. Associations of periodontal status in periodontitis and rheumatoid arthritis patients. J Periodontal Implant Sci 2021; 51: 124–134, DOI: 10.5051/jpis.2006060303.
25.
Mobini M, Maboudi A, Ali Mohammadpour R. Periodontitis in rheumatoid arthritis patients, abundance and association with disease activity. Med J Islam Repub Iran 2017; 31: 44–49, DOI: 10.14196/mjiri.31.44.
26.
Beyer K, Zaura E, Brandt BW, et al. Subgingival microbiome of rheumatoid arthritis patients in relation to their disease status and periodontal health. PLoS One 2018; 13: e0202278, DOI: 10.1371/journal.pone.0202278.
27.
Podzimek S, Mysak J, Janatova T, et al. C-Reactive Protein in Peripheral Blood of Patients with Chronic and Aggressive Periodontitis, Gingivitis, and Gingival Recessions. Mediators Inflamm 2015; 2015: 564858, DOI: 10.1155/2015/564858.
28.
Bizzarro S, van der Velden U, Ten Heggeler JMAG, et al. Periodontitis is characterized by elevated PAI-1 activity. J Clin Periodontol 2007; 34: 574–580, DOI: 10.1111/j.1600-051X.2007.01095.x.
29.
Bolla V, Kumari PS, Munnangi SR, et al. Evaluation of Serum C-reactive Protein Levels in Subjects with Aggressive and Chronic Periodontitis in Comparison with Healthy Controls: A Clinico-biochemical Study. Int J Appl Basic Med Res 2017; 7: 121–124, DOI: 10.4103/2229-516X.205814.
30.
Gupta S, Suri P, Patil PB, et al. Comparative evaluation of role of hs C-reactive protein as a diagnostic marker in chronic periodontitis patients. J Family Med Prim Care 2020; 9: 1340–1347, DOI: 10.4103/jfmpc.jfmpc_1063_19.
31.
Botelho J, Machado V, Hussain SB, et al. Periodontitis and circulating blood cell profiles: a systematic review and meta-analysis. Exp Hematol 2021; 93: 1–13, DOI: 10.1016/j.exphem.2020.10.001.
32.
Choudhury P, Chakraborty M. Relation between anemia and periodontitis with blood parameters in Silchar, Assam. J Adv Med Dent Sci 2019; 7: 193–195, DOI: 10.21276/jamdsr.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.